The South African Health Products Regulatory Authority (SAHPRA) worked together with the SANDF, SAPS, Hawks, Metro Police, Department of Home Affairs, Department of Transport and Adams & Adams to seize a shipment containing prohibited skin lightening creams, unregistered medicines and registered schedule 4 medicines worth...
The South African Health Products Regulatory Authority (SAHPRA) has become aware of possible contamination of metformin-containing medicines with NDMA. NDMA is classified as a probable human carcinogen (a substance that could cause cancer) based on results of studies conducted in animals. NDMA is a known...
The South African Police Service is issuing a stern warning that the establishment of illegal dispensaries/outlets, online sites and social media platforms which are marketing and selling cannabis and cannabis-related products to the public remains illegal, except where specifically allowed in terms of the Medicines...
The South African Health Products Regulatory Authority (SAHPRA) would like to update and reassure the public on the status of ranitidine-containing medicines in response to recent renewed concerns about contamination with N-nitrosodimethylamine (NDMA) impurities. NMDA is classified as a probable human carcinogen (substance that could...
Between 60 and 100 chemicals called cannabinoids and some 300 non-cannabinoid chemicals are produced by the cannabis plant. Delta-9 tetrahydrocannabinol (THC) and cannabidiol (CBD) are two of the many cannabinoids present in the cannabis plant, in varying concentrations. THC is psychoactive in nature and is...
In February 2019 the South African Health Products Regulatory Authority (SAHPRA) received reports suggesting fraudulent activity implicating a small sector of the authority and an external stakeholder. SAHPRA’s acting-CEO, the Board and the Health Minister reported the allegations to the Special Investigating Unit (SIU) and...
The South African Health Products Regulatory Authority (SAHPRA) notes with concern the statement made on Cape Talk Radio that the regulatory authority has issued the first commercial licences for the growing and manufacturing of cannabis. The mandate of the regulatory authority is to issue licences...
The South African Health Products Regulatory Authority (SAHPRA) has learned about the safety concerns regarding the presence of a nitrosamine impurity called NDMA in ranitidine-containing medicines. NDMA is classified as a probable human carcinogen (a substance that could cause cancer) based on the results of...
SAHPRA is pleased to announce the appointment of a new Chief Executive Officer, Dr Boitumelo Semete-Makokotlela, who will commence with this role in January 2020. Dr Semete-Makokotlela holds a Ph.D. in Biochemistry (North-West University) and an MSc in Management Finance and Investment from Wits Business...
Mr Khamusi Mutoti, Biological Medicine Manager at SAHPRA, was elected the Chairperson of the African Blood Regulator’s Forum (ABRF) during the African Medicines Regulation Conference (AMRC) held at Elephant Hill Hotel, Victoria Falls, Zimbabwe on 2 – 4 October 2019. Mr Mutoti who is also an...